Top stories
Sort by: Newest first Oldest first A-Z Z-A
-
Yellow Card app allows users to monitor adverse drug reaction reports Subscription
A free smartphone app of the UK’s Yellow Card Scheme allows healthcare professionals, patients and others to report and monitor adverse drug reactions.
-
World’s most expensive drug gets green light from NICE Subscription
The National Institute for Health and Care Excellence has paved the way for making the most expensive drug in the world available on the NHS.
-
WHO lists bacteria that need to be targeted for antibiotic development
The World Health Organization has drawn up a list of families of bacteria that pose the greatest risk to human health and which should be targeted by drug companies when developing new antibiotics.
-
WHO joins drive to make all clinical trial data publicly available Subscription
The World Health Organization has issued an official statement to encourage pharmaceutical companies to publicly disclose clinical trial results.
-
Welsh government proposes introducing pharmaceutical needs assessments from April 2020
Health boards in Wales may be required to conduct pharmaceutical needs assessments from 1 April 2020.
-
Vitamin B12 study hints at a molecular mechanism for acne pathogenesis Subscription
Taking vitamin B12 supplements affects the genes expressed by bacteria living on our skin, report researchers at the University of California, Los Angeles in Science Translational Medicine.
-
'Very few people' likely to get prescription for medical cannabis as it becomes legal in the UK
Prescriptions for medical cannabis are likely to be available for “very few people in England”, according to NHS guidance for patients, published on 1 November 2018.
-
Valproate poses risk to unborn children, says European regulator Subscription
Review recommends that valproate should not be prescribed to treat bipolar disorder or epilepsy in pregnant women or women or girls of childbearing age unless there is no alternative product.
-
US study shows increase in risk of drug interactions Subscription
The proportion of older adults in the United States at risk of major drug-drug interactions increased from 8.4% to 15.1% over five years, according to an analysis published in JAMA Internal Medicine.
-
US neurologists warn against long-term opioid use for non-cancer pain Subscription
Half of patients taking opioids for at least three months are still taking them five years later, with long-term use associated with serious risk of overdose or addiction.
